E
Kezar Life Sciences, Inc. KZR
$3.96 -$0.04-1.00% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 28.18% 22.40% 17.80% -9.10% -19.43%
Total Depreciation and Amortization -6.12% -3.37% -2.44% 110.93% 57.98%
Total Amortization of Deferred Charges 34.55% 47.50% 10.21% 9.57% 9.82%
Total Other Non-Cash Items -43.39% -28.66% -33.01% -3.06% 40.93%
Change in Net Operating Assets -188.93% -135.39% -127.62% 278.08% 202.14%
Cash from Operations 18.68% 18.06% 9.10% 2.78% -5.86%
Capital Expenditure 72.99% 97.55% 98.40% 99.12% 94.77%
Sale of Property, Plant, and Equipment -- -- -- -100.00% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -7.86% -9.53% 3.35% 103.06% 6,951.90%
Cash from Investing -7.76% -7.87% 5.76% 114.04% 2,194.73%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -48.10% -78.72% -83.86% -89.40% -87.12%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -1,698.73% -348.14% -83.86% -89.40% -87.12%
Foreign Exchange rate Adjustments -300.00% -1,800.00% -3,050.00% 4,900.00% 140.74%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 3,547.31% 228.19% 226.05% 122.03% 100.22%